Daiwa Securities Group
NXTC icon

Daiwa Securities Group’s NextCure NXTC Stock Holding History

Daiwa Securities Group’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4
Closed – – 1358
2022
Q3 		$0 Hold
4
– – ﹤0.01% 1370
2022
Q2 		$0 Hold
4
– – ﹤0.01% 1404
2022
Q1 		$0 Hold
4
– – ﹤0.01% 1402
2021
Q4 		$0 Hold
4
– – ﹤0.01% 1427
2021
Q3 		$0 Hold
4
– – ﹤0.01% 1331
2021
Q2 		$0 Hold
4
– – ﹤0.01% 1281
2021
Q1 		$1K Hold
4
– – ﹤0.01% 1213
2020
Q4 		$1K Buy
+4
New +$517 ﹤0.01% 1192

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Daiwa Securities Group's NXTC Position: Q4 2022 in Review

Daiwa Securities Group sold out of NextCure (NXTC) in Q4 2022, closing a stake of 4 shares.

Daiwa Securities Group first reported a position in NXTC in Q4 2020 and held it in 8 quarters. The position peaked at $1K in Q1 2021. 45 funds tracked by Wall St. Rank hold NXTC as of Q4 2022.

  • Daiwa Securities Group reported no remaining NextCure position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 4 NextCure shares in Q4 2022.
  • Daiwa Securities Group first reported a position in NextCure in Q4 2020 and held it in 8 quarters.
  • Daiwa Securities Group's NextCure position peaked at $1K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held NextCure as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.